Dyslipidemia and atherosclerosis: how much more evidence do we need?

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): A retrospective cohort study of individuals with FH in UK primary care and the UK Simon Broome register, linked with national hospital records.

Atherosclerosis·2025

Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.

Atherosclerosis·2018

Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

European journal of preventive cardiology·2011

Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1).

Diabetic medicine : a journal of the British Diabetic Association·2010

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study.

Atherosclerosis·2010

Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations.

Atherosclerosis·2009

Lipids in endothelial-to-mesenchymal transition.

Current opinion in lipidology·2026

Atherosclerosis resolution: strategies to remodel and resolve plaques.

Current opinion in lipidology·2026

Lipids and lipoproteins in calcific aortic valve disease.

Current opinion in lipidology·2026

HDL-associated proteins affecting CVD and systemic inflammation.

Current opinion in lipidology·2026

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026

Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.

Rheumatology (Oxford, England)·2026

Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.

The British journal of radiology·2026

Myocardial Calcification After Severe Sepsis: 3-Patient Case Series, Multimodality Imaging, and Review of the Literature.

JACC. Case reports·2026

One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.

Molecular medicine reports·2026

BIOCARD framework: integrating fecal bile acids, lipids, and metabolites to assess response to a cardiovascular health intervention.

Gut microbes·2026

Related Experiment Videos

Dyslipidemia and atherosclerosis: how much more evidence do we need?

Related Concept Videos

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): A retrospective cohort study of individuals with FH in UK primary care and the UK Simon Broome register, linked with national hospital records.

Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.

Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1).

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study.

Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations.

Lipids in endothelial-to-mesenchymal transition.

Atherosclerosis resolution: strategies to remodel and resolve plaques.

Lipids and lipoproteins in calcific aortic valve disease.

HDL-associated proteins affecting CVD and systemic inflammation.

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.

Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.

Myocardial Calcification After Severe Sepsis: 3-Patient Case Series, Multimodality Imaging, and Review of the Literature.

One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.

Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.

BIOCARD framework: integrating fecal bile acids, lipids, and metabolites to assess response to a cardiovascular health intervention.

Related Experiment Videos

Dyslipidemia and atherosclerosis: how much more evidence do we need?

Related Concept Videos

Related Articles